276 related articles for article (PubMed ID: 16533805)
1. Interacting JNK-docking sites in MKK7 promote binding and activation of JNK mitogen-activated protein kinases.
Ho DT; Bardwell AJ; Grewal S; Iverson C; Bardwell L
J Biol Chem; 2006 May; 281(19):13169-13179. PubMed ID: 16533805
[TBL] [Abstract][Full Text] [Related]
2. A docking site in MKK4 mediates high affinity binding to JNK MAPKs and competes with similar docking sites in JNK substrates.
Ho DT; Bardwell AJ; Abdollahi M; Bardwell L
J Biol Chem; 2003 Aug; 278(35):32662-72. PubMed ID: 12788955
[TBL] [Abstract][Full Text] [Related]
3. Selectivity of docking sites in MAPK kinases.
Bardwell AJ; Frankson E; Bardwell L
J Biol Chem; 2009 May; 284(19):13165-73. PubMed ID: 19196711
[TBL] [Abstract][Full Text] [Related]
4. Filamin associates with stress signalling kinases MKK7 and MKK4 and regulates JNK activation.
Nakagawa K; Sugahara M; Yamasaki T; Kajiho H; Takahashi S; Hirayama J; Minami Y; Ohta Y; Watanabe T; Hata Y; Katada T; Nishina H
Biochem J; 2010 Mar; 427(2):237-45. PubMed ID: 20156194
[TBL] [Abstract][Full Text] [Related]
5. Structure and dynamics of the MKK7-JNK signaling complex.
Kragelj J; Palencia A; Nanao MH; Maurin D; Bouvignies G; Blackledge M; Jensen MR
Proc Natl Acad Sci U S A; 2015 Mar; 112(11):3409-14. PubMed ID: 25737554
[TBL] [Abstract][Full Text] [Related]
6. Synergistic activation of stress-activated protein kinase 1/c-Jun N-terminal kinase (SAPK1/JNK) isoforms by mitogen-activated protein kinase kinase 4 (MKK4) and MKK7.
Fleming Y; Armstrong CG; Morrice N; Paterson A; Goedert M; Cohen P
Biochem J; 2000 Nov; 352 Pt 1(Pt 1):145-54. PubMed ID: 11062067
[TBL] [Abstract][Full Text] [Related]
7. c-Jun N-terminal kinase binding domain-dependent phosphorylation of mitogen-activated protein kinase kinase 4 and mitogen-activated protein kinase kinase 7 and balancing cross-talk between c-Jun N-terminal kinase and extracellular signal-regulated kinase pathways in cortical neurons.
Repici M; Mare L; Colombo A; Ploia C; Sclip A; Bonny C; Nicod P; Salmona M; Borsello T
Neuroscience; 2009 Mar; 159(1):94-103. PubMed ID: 19135136
[TBL] [Abstract][Full Text] [Related]
8. Reverse two-hybrid screening identifies residues of JNK required for interaction with the kinase interaction motif of JNK-interacting protein-1.
Barr RK; Hopkins RM; Watt PM; Bogoyevitch MA
J Biol Chem; 2004 Oct; 279(41):43178-89. PubMed ID: 15271995
[TBL] [Abstract][Full Text] [Related]
9. Docking interactions of the JNK scaffold protein WDR62.
Cohen-Katsenelson K; Wasserman T; Khateb S; Whitmarsh AJ; Aronheim A
Biochem J; 2011 Nov; 439(3):381-90. PubMed ID: 21749326
[TBL] [Abstract][Full Text] [Related]
10. Human mitogen-activated protein kinase kinase 7 (MKK7) is a highly conserved c-Jun N-terminal kinase/stress-activated protein kinase (JNK/SAPK) activated by environmental stresses and physiological stimuli.
Foltz IN; Gerl RE; Wieler JS; Luckach M; Salmon RA; Schrader JW
J Biol Chem; 1998 Apr; 273(15):9344-51. PubMed ID: 9535930
[TBL] [Abstract][Full Text] [Related]
11. Docking sites on mitogen-activated protein kinase (MAPK) kinases, MAPK phosphatases and the Elk-1 transcription factor compete for MAPK binding and are crucial for enzymic activity.
Bardwell AJ; Abdollahi M; Bardwell L
Biochem J; 2003 Mar; 370(Pt 3):1077-85. PubMed ID: 12529172
[TBL] [Abstract][Full Text] [Related]
12. MEK kinase 3 directly activates MKK6 and MKK7, specific activators of the p38 and c-Jun NH2-terminal kinases.
Deacon K; Blank JL
J Biol Chem; 1999 Jun; 274(23):16604-10. PubMed ID: 10347227
[TBL] [Abstract][Full Text] [Related]
13. Arrestin-3 binds c-Jun N-terminal kinase 1 (JNK1) and JNK2 and facilitates the activation of these ubiquitous JNK isoforms in cells via scaffolding.
Kook S; Zhan X; Kaoud TS; Dalby KN; Gurevich VV; Gurevich EV
J Biol Chem; 2013 Dec; 288(52):37332-42. PubMed ID: 24257757
[TBL] [Abstract][Full Text] [Related]
14. Combining docking site and phosphosite predictions to find new substrates: identification of smoothelin-like-2 (SMTNL2) as a c-Jun N-terminal kinase (JNK) substrate.
Gordon EA; Whisenant TC; Zeller M; Kaake RM; Gordon WM; Krotee P; Patel V; Huang L; Baldi P; Bardwell L
Cell Signal; 2013 Dec; 25(12):2518-29. PubMed ID: 23981301
[TBL] [Abstract][Full Text] [Related]
15. Anthrax lethal factor-cleavage products of MAPK (mitogen-activated protein kinase) kinases exhibit reduced binding to their cognate MAPKs.
Bardwell AJ; Abdollahi M; Bardwell L
Biochem J; 2004 Mar; 378(Pt 2):569-77. PubMed ID: 14616089
[TBL] [Abstract][Full Text] [Related]
16. A novel retro-inverso peptide is a preferential JNK substrate-competitive inhibitor.
Ngoei KR; Catimel B; Milech N; Watt PM; Bogoyevitch MA
Int J Biochem Cell Biol; 2013 Aug; 45(8):1939-50. PubMed ID: 23792175
[TBL] [Abstract][Full Text] [Related]
17. Synoviocyte innate immune responses: I. Differential regulation of interferon responses and the JNK pathway by MAPK kinases.
Yoshizawa T; Hammaker D; Sweeney SE; Boyle DL; Firestein GS
J Immunol; 2008 Sep; 181(5):3252-8. PubMed ID: 18713996
[TBL] [Abstract][Full Text] [Related]
18. Docking interactions in the c-Jun N-terminal kinase pathway.
Mooney LM; Whitmarsh AJ
J Biol Chem; 2004 Mar; 279(12):11843-52. PubMed ID: 14699111
[TBL] [Abstract][Full Text] [Related]
19. PP2A regulates upstream members of the c-jun N-terminal kinase mitogen-activated protein kinase signaling pathway.
Zhao B; Sun L; Haas M; Denenberg AG; Wong HR; Shanley TP
Shock; 2008 Feb; 29(2):181-8. PubMed ID: 17693927
[TBL] [Abstract][Full Text] [Related]
20. Molecular cloning and characterization of a human protein kinase that specifically activates c-Jun N-terminal kinase.
Yang J; New L; Jiang Y; Han J; Su B
Gene; 1998 May; 212(1):95-102. PubMed ID: 9661668
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
